IS5577A - Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar - Google Patents

Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar

Info

Publication number
IS5577A
IS5577A IS5577A IS5577A IS5577A IS 5577 A IS5577 A IS 5577A IS 5577 A IS5577 A IS 5577A IS 5577 A IS5577 A IS 5577A IS 5577 A IS5577 A IS 5577A
Authority
IS
Iceland
Prior art keywords
pharmaceutical compositions
production process
protected against
gastric acid
omeprazole
Prior art date
Application number
IS5577A
Other languages
English (en)
Other versions
IS2866B (is
Inventor
Debregeas Patrice
Leduc Gérard
Oury Pascal
Suplie Pascal
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9522415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5577(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of IS5577A publication Critical patent/IS5577A/is
Publication of IS2866B publication Critical patent/IS2866B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS5577A 1998-01-30 2000-07-25 Magavarin ómeprasólörkorn, aðferð til að fá slík og lyfjaefnablöndur IS2866B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801098A FR2774288B1 (fr) 1998-01-30 1998-01-30 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR1998/001783 WO1999038511A1 (fr) 1998-01-30 1998-08-10 Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (2)

Publication Number Publication Date
IS5577A true IS5577A (is) 2000-07-25
IS2866B IS2866B (is) 2014-01-15

Family

ID=9522415

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5577A IS2866B (is) 1998-01-30 2000-07-25 Magavarin ómeprasólörkorn, aðferð til að fá slík og lyfjaefnablöndur

Country Status (31)

Country Link
US (1) US6551621B1 (is)
EP (1) EP1051174B2 (is)
JP (1) JP4286452B2 (is)
KR (1) KR100510366B1 (is)
CN (1) CN1114405C (is)
AT (1) ATE232100T1 (is)
AU (1) AU755882B2 (is)
BG (1) BG65087B1 (is)
BR (1) BR9814924B1 (is)
CA (1) CA2319015C (is)
CZ (1) CZ299192B6 (is)
DE (1) DE69811278T3 (is)
DK (1) DK1051174T4 (is)
EA (1) EA002879B1 (is)
EE (1) EE05620B1 (is)
ES (1) ES2189232T5 (is)
FR (1) FR2774288B1 (is)
GE (1) GEP20032941B (is)
HU (1) HU229956B1 (is)
IL (1) IL137536A0 (is)
IS (1) IS2866B (is)
NO (1) NO330144B1 (is)
NZ (1) NZ505998A (is)
PL (1) PL200043B1 (is)
PT (1) PT1051174E (is)
RS (1) RS50245B (is)
SI (1) SI1051174T2 (is)
SK (1) SK285666B6 (is)
TR (1) TR200002214T2 (is)
UA (1) UA61988C2 (is)
WO (1) WO1999038511A1 (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
WO2005076987A2 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
EP1742630A4 (en) * 2004-04-16 2010-01-20 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND PROKINETIC AGENT
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
KR101784001B1 (ko) 2006-04-04 2017-10-23 케이지 액퀴지션 엘엘씨 항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2081546A2 (en) * 2006-10-17 2009-07-29 Ranbaxy Laboratories Limited Multiple unit tablet compositions of benzimidazole compounds
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
EP3117824A1 (en) 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
FI3324948T3 (fi) 2015-07-17 2023-05-05 Be Pharbel Mfg Monikerroksisia farmaseuttisesti aktiivista yhdistettä vapauttavia mikropartikkeleita nestemäisessä annosmuodossa
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
AU4129496A (en) * 1994-09-30 1996-04-26 Medical Security Corporation Method and system for cleaning and slip-resistant treatment of surface coverings
ES2094694B1 (es) † 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
ATE286394T1 (de) * 1995-09-21 2005-01-15 Pharma Pass Ii Llc Ein säurelabile omeprazol enthaltende arzneizusammensetzung und verfahren zu deren herstellung
WO1998019668A1 (en) * 1996-11-06 1998-05-14 Sharmatek, Inc. Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I

Also Published As

Publication number Publication date
DK1051174T4 (da) 2012-10-01
DE69811278T3 (de) 2012-11-29
KR100510366B1 (ko) 2005-08-24
JP2002501895A (ja) 2002-01-22
PL200043B1 (pl) 2008-11-28
US6551621B1 (en) 2003-04-22
CN1114405C (zh) 2003-07-16
EE200000466A (et) 2002-04-15
CN1284877A (zh) 2001-02-21
SK285666B6 (sk) 2007-05-03
BR9814924B1 (pt) 2010-07-13
FR2774288B1 (fr) 2001-09-07
CA2319015A1 (fr) 1999-08-05
SI1051174T2 (sl) 2013-01-31
NO330144B1 (no) 2011-02-21
HUP0100347A3 (en) 2002-12-28
EE05620B1 (et) 2013-02-15
UA61988C2 (uk) 2003-12-15
ATE232100T1 (de) 2003-02-15
FR2774288A1 (fr) 1999-08-06
AU9074898A (en) 1999-08-16
EA200000797A1 (ru) 2001-02-26
EA002879B1 (ru) 2002-10-31
JP4286452B2 (ja) 2009-07-01
ES2189232T3 (es) 2003-07-01
YU48400A (sh) 2003-02-28
CZ20002709A3 (cs) 2000-12-13
PT1051174E (pt) 2003-06-30
DE69811278D1 (de) 2003-03-13
HK1032354A1 (en) 2001-07-20
AU755882B2 (en) 2003-01-02
CZ299192B6 (cs) 2008-05-14
IL137536A0 (en) 2001-07-24
TR200002214T2 (tr) 2000-12-21
BG104634A (bg) 2001-02-28
IS2866B (is) 2014-01-15
HUP0100347A2 (hu) 2001-10-28
NZ505998A (en) 2003-11-28
PL342044A1 (en) 2001-05-21
SI1051174T1 (sl) 2003-06-30
HU229956B1 (hu) 2015-03-02
EP1051174B2 (fr) 2012-07-04
GEP20032941B (en) 2003-04-25
DK1051174T3 (da) 2003-05-26
BG65087B1 (bg) 2007-02-28
EP1051174A1 (fr) 2000-11-15
SK11412000A3 (sk) 2001-04-09
CA2319015C (fr) 2008-08-05
NO20004654D0 (no) 2000-09-18
ES2189232T5 (es) 2012-11-07
DE69811278T2 (de) 2003-11-27
RS50245B (sr) 2009-07-15
WO1999038511A1 (fr) 1999-08-05
KR20010040502A (ko) 2001-05-15
EP1051174B1 (fr) 2003-02-05
NO20004654L (no) 2000-09-18
BR9814924A (pt) 2000-10-17

Similar Documents

Publication Publication Date Title
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
NO20016108L (no) Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
IL166561A0 (en) Pharmaceutical compositions
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
MXPA00001924A (es) Material de encapsulacion libre de gelatina flexible util para farmaceuticos, pelotas de pintura y otras formulaciones.
DK0981334T3 (da) Slugetabletter indeholdende paracetamol
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
DE69941825D1 (de) Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
TR199900548A3 (tr) Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
DE60004815D1 (de) Gegen magensaft geschützte omeprazol-mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
NO20020243L (no) Lavdosetabletter og fremgangsmåte for fremstilling av disse
WO2003026621A3 (fr) Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
ITRM950421A0 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare, procedimento per la loro preaparazione e composizioni farmaceutiche che li contengono.
ITUD20030196A1 (it) Procedimento per la preparazione di dosaggi farmaceutici contenenti molteplici principi attivi.
IT248430Y1 (it) Elemento di aggancio e di snodo per la realizzazione di catene, monilio simili.